Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
Open Access
- 1 October 1994
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 94 (4) , 1570-1576
- https://doi.org/10.1172/jci117498
Abstract
Insulin-mediated vasodilation has been proposed as a determinant of in vivo insulin sensitivity. We tested whether sustained vasodilation with adenosine could overcome the muscle insulin resistance present in mildly overweight patients with essential hypertension. Using the forearm technique, we measured the response to a 40-min local intraarterial infusion of adenosine given under fasting conditions (n = 6) or superimposed on a euglycemic insulin clamp (n = 8). In the fasting state, adenosine-induced vasodilation (forearm blood flow from 2.6 +/- 0.6 to 6.0 +/- 1.2 ml min-1dl-1, P < 0.001) was associated with a 45% rise in muscle oxygen consumption (5.9 +/- 1.0 vs 8.6 +/- 1.7 mumol min-1dl-1, P < 0.05), and a doubling of forearm glucose uptake (0.47 +/- 0.15 to 1.01 +/- 0.28 mumol min-1dl-1, P < 0.05). The latter effect remained significant also when expressed as a ratio to concomitant oxygen balance (0.08 +/- 0.03 vs 0.13 +/- 0.04 mumol mumol-1, P < 0.05), whereas for all other metabolites (lactate, pyruvate, FFA, glycerol, citrate, and beta-hydroxybutyrate) this ratio remained unchanged. During euglycemic hyperinsulinemia, whole-body glucose disposal was stimulated (to 19 +/- 3 mumol min-1kg-1), but forearm blood flow did not increase significantly above baseline (2.9 +/- 0.2 vs 3.1 +/- 0.2 ml min-1dl-1, P = NS). Forearm oxygen balance increased (by 30%, P < 0.05) and forearm glucose uptake rose fourfold (from 0.5 to 2.3 mumol min-1dl-1, P < 0.05). Superimposing an adenosine infusion into one forearm resulted in a 100% increase in blood flow (from 2.9 +/- 0.2 to 6.1 +/- 0.9 ml min-1dl-1, P < 0.001); there was, however, no further stimulation of oxygen or glucose uptake compared with the control forearm. During the clamp, the ratio of glucose to oxygen uptake was similar in the control and in the infused forearms (0.27 +/- 0.11 and 0.23 +/- 0.09, respectively), and was not altered by adenosine (0.31 +/- 0.9 and 0.29 +/- 0.10). We conclude that in insulin-re15-76sistant patients with hypertension, adenosine-induced vasodilation recruits oxidative muscle tissues and exerts a modest, direct metabolic effect to promote muscle glucose uptake in the fasting state. Despite these effects, however, adenosine does not overcome muscle insulin resistance.Keywords
This publication has 23 references indexed in Scilit:
- Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.Journal of Clinical Investigation, 1990
- Microvascular rarefaction and tissue vascular resistance in hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 1988
- Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*Journal of Clinical Endocrinology & Metabolism, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Increased muscle glucose uptake during contractions: no need for insulinAmerican Journal of Physiology-Endocrinology and Metabolism, 1984
- Effect of fatty acids on glucose production and utilization in man.Journal of Clinical Investigation, 1983
- Active and passive capillary control in red muscle at rest and in exerciseAmerican Journal of Physiology-Heart and Circulatory Physiology, 1982
- The effects of intra-arterial adenosine infusion on substrate levels and blood flow in skeletal muscle of the dogNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- FOREARM METABOLISM IN OBESITY AND ITS RESPONSE TO INTRA-ARTERIAL INSULIN. CHARACTERIZATION OF INSULIN RESISTANCE AND EVIDENCE FOR ADAPTIVE HYPERINSULINISM*Journal of Clinical Investigation, 1962